TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
99,107
|
88,724
|
78,312 |
| Financial expenses |
64
|
16
|
51 |
| Earnings before taxes |
-16,919
|
-7,172
|
5,426 |
| EBITDA |
-12,397
|
-5,527
|
10,309 |
| Total assets |
89,082
|
93,039
|
67,804 |
| Current assets |
58,228
|
62,213
|
53,665 |
| Current liabilities |
37,426
|
34,662
|
35,849 |
| Equity capital |
51,657
|
58,282
|
29,579 |
| - share capital |
123
|
116
|
51 |
| Employees (average) |
56
|
52
|
51 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.0%
|
62.6%
|
43.6% |
| Turnover per employee |
1,770
|
1,706
|
1,536 |
| Profit as a percentage of turnover |
-17.1%
|
-8.1%
|
6.9% |
| Return on assets (ROA) |
-18.9%
|
-7.7%
|
8.1% |
| Current ratio |
155.6%
|
179.5%
|
149.7% |
| Return on equity (ROE) |
-32.8%
|
-12.3%
|
18.3% |
| Change turnover |
8,783
|
4,855
|
8,468 |
| Change turnover % |
10%
|
6%
|
12% |
| Chg. No. of employees |
4
|
1
|
12 |
| Chg. No. of employees % |
8%
|
2%
|
31% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.